Equity Research, Broker Reports, and media content on HUTCHMED (China) Limited

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about HUTCHMED (China) Limited
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

HUTCHMED (China) Limited

Company Profile

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on HUTCHMED (China) Limited. We currently have 133 research reports from 4 professional analysts.

  • Open: 266p
  • Range Today: 266/267p
  • 52 Week: 174/338p
  • Daily Volume: 1.7k
  • Daily Liquidity: 0.00%
  • # Shares: 871.3m
  • Market Cap: £2,302m
  • Latest PE (hist):
  • Div Yield:
Date Source Announcement
28Mar24 07:00 RNS Hutchmed China Ltd - Savolitinib sNDA Accepted in China
22Mar24 07:00 RNS Hutchmed China Ltd - Initiation of Registration Stage of P2/3 Trial
14Mar24 09:00 RNS Hutchmed China Ltd - LTIP and Share Option Scheme
05Mar24 08:30 RNS Hutchmed China Ltd - Vesting of awards under the LTIP
28Feb24 12:45 RNS Hutchmed China Ltd - Publication of Form 20-F
28Feb24 11:30 RNS Hutchmed China Ltd - 2023 Full Year Results and Business Updates
07Feb24 07:00 RNS Hutchmed China Ltd - Presentation of Phase III Data on Fruquintinib
  • Frequency of research reports

     

  • Research reports on

    HUTCHMED (China) Limited

  • Providers covering

    HUTCHMED (China) Limited